PHARMACEUTICAL COMPOSITIONS INCLUDING ACE/NEP INHIBITORS AND BIOAVAILABILITY ENHANCERS
Patent №
US 6,890,918
Granted
2005-05-10
Filed 2002
Owner
SHIRE BIOCHEM INC.
+2 more
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10134651
A pharmaceutical composition comprising an inhibitor of angiotensin converting enzyme and neutral endopeptidase, such as sampatrilat, and at least one bioavailability enhancer such as an organic acid, e.g., ascorbic acid. Such a composition has improved systemic bioavailability.
AI hardwareA61K 47/28A61K 9/485A61K 9/4858A61K 31/197A61K 31/198A61K 31/343A61K 31/357A61K 31/40+7 more
AI classification
AI hardware0.59
Machine learning0.02
Natural language0.00
Evolutionary computation0.00
Vision0.00
Speech0.00
Knowledge representation0.00
Planning0.00
Ownership
SHIRE BIOCHEM INC.
assignment · 131630638
SHIRE LABORATORIES INC.
assignment · 146330051
SUPERNUS PHARMACEUTICALS, INC
assignment · 175960304
Assignors
BURNSIDE, BETH, CHANG, RONG-KUN, SHOJAEI, AMIR
On an employer assignment, the assignors are typically the inventors.